The 4th Non-Alcoholic Steatohepatitis (NASH) Summit will bring together industry stakeholders to accelerate the development of NASH and NAFLD .. Read more therapies. Exclusively gathering NASH and fibrosis stakeholders across 4 days of back-to-back content, the digital 4th NASH Summit (Boston, December 15-18 2020) is the most comprehensive and definitive opportunity for biopharma to understand the latest scientific insights and solutions from target identification through to clinical trial approval. Capturing exclusive presentations from key opinion leaders, regulatory bodies, biopharma program heads and pioneering patient advocates, hear from 70+ speakers and 350+ attendees all with one mission: to accelerate the successful development of NASH candidates. Networking: Network one-to-one with 350 other key decision makers across multiple perspectives prioritizing NASH. Meet and collaborate with discovery, translational and safety scientists, as well as clinical program and market access leads and scientists developing innovative preclinical and non-invasive technologies.
- Share your Experience
More Events From The Organizer
- LEAP HR: Emerging Biopharma30 Nov - 02 Dec 2020Online